Ledger.Open graph →
SEC Form D · filed April 6, 2023

Phi Therapeutics, Inc

Offering
$7.7M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PETALUMA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jun Li · PETALUMA, CADirectorYug Varma · PETALUMA, CAExec · DirectorNeil Giugno · PETALUMA, CAExec · DirectorYew Poh Leong · Singapore, U0Exec · DirectorHsien Loong Wong · Singapore, U0Exec · DirectorMike Zelkind · Hamilton, OHDirectorJames Cleary · Grand Cayman, Cayman IslandsDirectorAnne Wynne · New York, NYExec · DirectorJohn W. Honeybourne · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗